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Abstract
Background: Antibiotic resistance of bacteria is on the rise, thus the discovery of alternative therapeutic agents is
urgently needed. Honey possesses therapeutic potential, including wound healing properties and antimicrobial activity.
Although the antimicrobial activity of honey has been effectively established against an extensive spectrum of
microorganisms, it differs depending on the type of honey. To date, no extensive studies of the antibacterial properties
of tualang (Koompassia excelsa) honey on wound and enteric microorganisms have been conducted. The objectives of this
study were to conduct such studies and to compare the antibacterial activity of tualang honey with that of manuka honey.
Methods: Using a broth dilution method, the antibacterial activity of tualang honey against 13 wound and enteric
microorganisms was determined; manuka honey was used as the control. Different concentrations of honey [6.25-25%
(w/v)] were tested against each type of microorganism. Briefly, two-fold dilutions of honey solutions were tested to
determine the minimum inhibitory concentration (MIC) against each type of microorganism, followed by more assays
within a narrower dilution range to obtain more precise MIC values. MICs were determined by both visual inspection
and spectrophotometric assay at 620 nm. Minimum bactericidal concentration (MBC) also was determined by culturing
on blood agar plates.
Results: By visual inspection, the MICs of tualang honey ranged from 8.75% to 25% compared to manuka honey (8.75-
20%). Spectrophotometric readings of at least 95% inhibition yielded MIC values ranging between 10% and 25% for both
types of honey. The lowest MBC for tualang honey was 20%, whereas that for manuka honey was 11.25% for the
microorganisms tested. The lowest MIC value (8.75%) for both types of honey was against Stenotrophomonas maltophilia.
Tualang honey had a lower MIC (11.25%) against Acinetobacter baumannii compared to manuka honey (12.5%).
Conclusion: Tualang honey exhibited variable activities against different microorganisms, but they were within the same
range as those for manuka honey. This result suggests that tualang honey could potentially be used as an alternative
therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.
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Background
Since ancient times, honey has been used for its medicinal
properties to treat a wide variety of ailments. In particular,
it has been used in wound dressings. In general, all types
of honey have high sugar content but a low water content
and acidity, which prevent microbial growth. Most types
of honey generate hydrogen peroxide when diluted
because of the activation of the enzyme glucose oxidase,
which oxidizes glucose to gluconic acid and hydrogen per-
oxide [1,2]. Hydrogen peroxide is the major contributor
to the antimicrobial activity of honey, and the different
concentrations of this compound in different honeys
result in their varying antimicrobial effects [1,3].
In most cases, the peroxide activity in honey can be
destroyed easily by heat or the presence of catalase. How-
ever,  Leptospermum  honeys retain their antimicrobial
activities even in the presence of catalase, thus they are
known as "non-peroxide honeys" [3]. Several compo-
nents may contribute to the non-peroxide activities, such
as the presence of methyl syringate and methylglyoxal,
which have been extensively studied in Leptospermum hon-
eys [4-6]. However, many other constituents that have yet
to be characterized are likely to contribute to honey's anti-
microbial properties.
Honey can inhibit the growth of a wide range of bacteria,
fungi, protozoa and viruses [3,7]. Microorganisms such as
Staphylococcus aureus,  Pseudomonas aeruginosa and
Escherichia coli frequently are isolated from skin wounds.
Methicillin-resistant S. aureus (MRSA) is involved in diffi-
cult-to-treat skin and underlying tissue infections associ-
ated with Gram-positive bacteria [8], while the most
serious complication in burn patients is associated with
infection with P. aeruginosa [9,10], followed by infections
with E. coli, S. aureus and other pathogenic microorgan-
isms [9]. Microorganisms that colonize a burn wound
originate from the patient's endogenous skin, gastrointes-
tinal and respiratory flora and via contact with contami-
nated external environmental surfaces, water, air and the
soiled hands of health care workers. Gram-positive bacte-
ria from the patient's endogenous skin flora or the exter-
nal environment predominantly colonize the burn
wound immediately, followed by endogenous Gram-neg-
ative bacteria from the patient's gastrointestinal flora in
the first few days after injury [11].
Besides its antimicrobial properties, honey can clear infec-
tion in a number of ways, including boosting the immune
system, having anti-inflammatory and antioxidant activi-
ties and via stimulation of cell growth [12]. The vast
amount of data about honey's therapeutic properties,
along with the rapidly increasing interest in and research
into natural health remedies and supplements, has led to
a resurgence in interest in honey's therapeutic uses.
Malaysian tualang honey is collected from the combs of
Asian rock bees (Apis dorsata), which build their hives high
up in the tualang tree (Koompassia excelsa). Tualang honey
is used commonly as a medicinal product [13,14] and as
food in Malaysia. However, little scientific information
about its microbiological properties has been published
to date. Thus, this study was designed to determine the
antibacterial activity of tualang honey by comparing it
with manuka honey, which has been extensively studied
[3,5].
Previously, Ainul Hafiza et al. [13] conducted a study of
five local honeys (Belimbing, Gelam, Durian, Kelapa and
Tualang); they conducted a microbial colony count using
a filtration method and a simple screening assay for anti-
bacterial action against Staphylococcus aureus using the
agar diffusion method. Tumin et al. [15] investigated the
antibacterial properties of tualang honey and four other
local Malaysian honeys against six bacterial species. In our
study, we examined the antibacterial activity of the local
Malaysian tualang honey against 13 different bacterial
species and compared it with the activity of manuka
honey. To our knowledge, this is the first study to reveal
the broad spectrum of antibacterial activities of the local
Malaysian tualang honey.
Methods
The antibacterial properties of tualang honey against 13
different bacterial species were determined by comparison
to the commercially available manuka honey (Kordel's,
UMF10+). Malaysian tualang honey was obtained from
Federal Agriculture Marketing Authority (FAMA), Kedah,
Malaysia, which was collected from Koompassia excelsa
(tualang tree). Both types of honey were stored in the dark
at room temperature. Initially, the honeys were subjected
to sterilization by γ-irradiation at a dose of 25 kGy fol-
lowed by a sterility test before they were subjected to the
various antimicrobial tests. We used this radiation dose
because it has been shown not to cause significant loss of
antibacterial activity [16] and because no viable clostridial
spores are present after the process [16,17].
The minimum inhibitory concentration (MIC) of the
honey was determined using the broth dilution method
in sterile 48-well microtiter plates with lids (Nunc,
Roskilde, Denmark). Fifty percent (w/v) stock solution of
each type of honey was prepared by weighing 10 g of the
honey and bringing the volume up to 20 ml using cation-
adjusted Mueller Hinton II broth (CAMHB) (Becton Dick-
inson, Maryland, USA). Further dilutions were done to
obtain honey concentrations of 6.25% (w/v), 7.5%,
8.75%, 10%, 11.25%, 12.5%, 15%, 17.5%, 20%, 22.5%
and 25%. The lowest concentration of honey that pre-
vented the growth of each microorganism, as detected by
lack of visual turbidity compared to a negative control,BMC Complementary and Alternative Medicine 2009, 9:34 http://www.biomedcentral.com/1472-6882/9/34
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was recorded as the MIC. All honey solutions were freshly
prepared before each assay.
The following procedure was followed for each microor-
ganism with each type of honey. A few single bacterial col-
onies from an overnight culture on blood agar (BA) were
inoculated into peptone water to achieve a turbidity of 0.5
McFarland (≈ 1 × 108 CFU/ml). The bacterial suspension
was further diluted with CAMHB to obtain a final concen-
tration of inoculum of 5 × 105 CFU/ml. The final volume
in each test well was 1 ml, consisting of 0.5 ml diluted
honey and 0.5 ml bacterial inoculum. For each assay, con-
trol wells included: 1) wells containing broth only (with-
out honey and inoculum); 2) wells containing broth and
inoculum (without honey); and 3) wells containing broth
and honey (without inoculum). The microtiter plates
were incubated at 35°C for 18 h. All tests were performed
in triplicate and were repeated three times to obtain relia-
ble results.
Growth was observed by visual inspection and by measur-
ing the optical density (OD) at 620 nm using a spectro-
photometer (VERSAmax, Massachusetts, USA). The OD
was measured immediately after the visual reading. The
growth inhibition for the test wells at each honey dilution
was determined by the formula: Percent inhibition = [1 -
(OD test well - OD corresponding negative control well)/
(OD viability control well - OD broth only well)] × 100%.
The minimum and maximum values were 0% and 100%,
respectively.
The microorganisms tested included five Gram-positive
bacteria [Streptococcus pyogenes (ATCC 19615), coagulase-
negative Staphylococci [local clinical isolates (l.c.i.)],
Methicillin-resistant Staphylococcus aureus (MRSA) (ATCC
33591), Streptococcus agalactiae (l.c.i.) and Staphylococcus
aureus (ATCC 25923)] and eight Gram-negative bacteria
[Stenotrophomonas maltophilia (l.c.i.),  Acinetobacter bau-
mannii  (l.c.i.),  Salmonella enterica Serovar  typhi  (l.c.i.),
Pseudomonas aeruginosa (ATCC 27853), Proteus mirabilis
(l.c.i.),  Shigella flexneri (l.c.i.),  Escherichia coli (ATCC
25922) and Enterobacter cloacae (l.c.i.)].
The minimum bactericidal concentration (MBC) was
determined by taking a loopful of the culture medium
from each test well (from the broth MIC assay) that
showed no apparent growth and sub-culturing on fresh
BA plates. After incubation at 35°C for 24 h, the MBC was
read as the least concentration showing no growth on the
BA plates.
Non-peroxide activity of both tualang and manuka hon-
eys were screened using the agar well diffusion method
adapted from Allen et al. [18] against S. aureus cultured on
the surface of Mueller Hinton agar. The 50% (w/v) solu-
tions of each honey were diluted to 25% (w/v) by taking
1 ml of each and adding it to either 1 ml of sterile purified
water (total activity) or 1 ml of catalase solution (non-per-
oxide activity). An 8000 U catalase solution (Sigma,
C9322: 2950 units/mg) was used to remove all the hydro-
gen peroxide present in the honeys. The removal of hydro-
gen peroxide was verified according to the method
described [18]. Blanks of water and catalase solution were
included.
Results
In this study, we compared the MIC values of tualang
honey and manuka honey determined by visual inspec-
tion and by a spectrophotometer. The MBC values of tua-
lang and manuka honeys also were compared.
Under visual inspection, the MICs for tualang honey
ranged from 8.75% (w/v) to 25%, while those for manuka
honey ranged between 8.75% and 20% (Table 1).
Manuka honey had lower MICs (indicating better activity)
than tualang honey against nine of the tested bacteria (S.
pyogenes, coagulase-negative Staphylococci, MRSA, S. aga-
lactiae,  S. aureus,  P. mirabilis,  S. flexneri,  E. coli and  E.
cloacae). However, when tested against A. baumannii, tua-
lang honey had a better MIC value (11.25%) compared to
that of manuka honey (12.5%). When tested against S.
typhi and P. aeruginosa, both honey types had equal MIC
values (15% and 17.5%, respectively). Both honey types
had the lowest MIC value (8.75%) and thus the best activ-
ity, against S. maltophilia. Additionally, the 8.75% dilution
of manuka honey showed good inhibition against the
growth of MRSA. The highest MIC values for tualang and
manuka honeys were against E. cloacae, at 25% and 20%
respectively. Tualang (20%) and manuka (11.25%) hon-
eys exhibited the greatest difference in MIC value against
S. aureus.
Spectrophotometric readings of at least 95% inhibition
(MIC95) gave MIC values that ranged between 10% and
25% for both honey types. Tualang honey had lower
MIC95 values than manuka honey when tested against
coagulase-negative Staphylococci, MRSA, A. baumannii
and S. typhi. However, manuka honey had lower MIC95
values compared to tualang honey when tested against S.
agalactiae, S. aureus, E. coli and E. cloacae. For the remain-
ing bacterial species, both types of honeys demonstrated
similar antimicrobial activities (Table 1).
For tualang honey, MIC95 values calculated from spectro-
photometric readings were the same as MIC values deter-
mined by visual inspection for six bacteria (S. pyogenes, S.
agalactiae, S. typhi, P. aeruginosa, E. coli and E. cloacae).
However, four bacteria (coagulase-negative Staphyloco-
cci, MRSA, S. aureus and A. baumannii) had slightly lower
(1.25-2.5%) spectrophotometric MIC95 values than visu-BMC Complementary and Alternative Medicine 2009, 9:34 http://www.biomedcentral.com/1472-6882/9/34
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ally determined MIC values, whereas three bacteria (S.
maltophilia, P. mirabilis and  S. flexneri) had increased
(1.25-5%) spectrophotometric MIC95 values compared to
visual MIC values.
For manuka honey, spectrophotometric MIC95 and visual
MIC values were the same for three bacteria (S. agalactiae,
A. baumannii and P. aeruginosa). The other ten bacteria
tested had greater spectrophotometric MIC95 (1.25-7.5%)
values compared to visual MIC values; the biggest differ-
ence between the two methods (7.5%) was seen with S.
flexneri.
Manuka honey had lower MBC values compared to tua-
lang honey (Table 2). Nine of the bacteria tested required
a concentration of greater than 25% tualang honey to kill
them, whereas only four species of bacteria needed this
concentration of manuka honey to be killed. The lowest
MBC value for tualang honey was 20% (against S. typhi),
whereas for manuka honey it was 11.25% (against S. mal-
tophilia).
Figures 1, 2, 3, 4 &5 show the patterns of bacterial growth
inhibition caused by exposure to different concentrations
of tualang and manuka honeys. Figure 1 shows that both
honeys caused similar inhibition of S. pyogenes growth but
tualang honey inhibited growth of coagulase-negative Sta-
phylococci better than manuka. Manuka honey caused
greater inhibition of MRSA growth than tualang honey at
concentrations from 6.25% to 11%, after which tualang
honey was the better inhibitor. Figure 2 illustrates that
both honeys caused similar inhibition of S. agalactiae and
S. aureus growth. The inhibition of S. aureus caused by tua-
lang honey was more gradual compared to that of
manuka honey.
Figure 3 shows similar patterns of inhibition of S. mal-
tophilia by both honeys. For A. baumanni, tualang honey
caused greater inhibition of growth from 7.5% onwards
compared to manuka honey. Both honeys caused similar
patterns of inhibition of S. typhi growth, with a gradual
increase followed by a sharp increase in inhibition around
11.25% to 15% (Figure 4). Manuka honey inhibited S.
flexneri growth better than tualang honey from 12.5% to
21.5%, but at greater concentrations tualang honey was
the better inhibitor. The effect of the honeys was different
for E. coli. Figure 5 shows that both honeys caused similar
patterns of growth inhibition of P. aeruginosa. For P.
mirabilis, manuka honey was a better inhibitor than tua-
lang honey from 12.5% to 22.5%. Inhibition of E. cloacae
growth began at 16.5% manuka honey and 20% tualang
honey, followed by drastic increase of inhibition.
The agar well diffusion assays performed showed that the
total activity and non-peroxide activity of the honeys were
similar, in which the inhibition zone diameter measured
was 24 mm for tualang honey and 26 mm for manuka
honey. However, it was noted that there was a thin layer
of growth of the organism in the zone of inhibition.
Discussion
Tualang honey is readily available in Malaysia, but its
quality and floral origin have yet to be determined and
standardized. In contrast, manuka honey has been widely
researched and its antibacterial potential is renowned
worldwide. Honeys with proven antibacterial potency
(UMF 10+ and above) have been recommended for
wound care preferentially over honeys of low or unknown
potency [19]. Therefore, manuka honey with UMF 10+
was chosen as a comparison for this study of the antimi-
crobial activity of tualang honey.
Table 1: MIC values (%) determined by visual inspection and spectrophotometric measurement
No. Microorganism Visual MIC (%) Spectrophotometric MIC95 (%)
Tualang Manuka Tualang Manuka
1 Streptococcus pyogenes 12.5 11.25 12.5 12.5
2 Coagulase-negative Staphylococci 12.5 11.25 11.25 12.5
3 Methicillin-resistant Staphylococcus aureus 12.5 8.75 11.25 12.5
4 Streptococcus agalactiae 20 15 20 15
5 Staphylococcus aureus 20 11.25 17.5 12.5
6 Stenotrophomonas maltophilia 8.75 8.75 10 10
7 Acinetobacter baumannii 11.25 12.5 10 12.5
8 Salmonella enterica Serovar typhi 15 15 15 17.5
9 Pseudomonas aeruginosa 17.5 17.5 17.5 17.5
10 Proteus mirabilis 20 17.5 22.5 22.5
11 Shigella flexneri 20 17.5 25 25
12 Escherichia coli 22.5 17.5 22.5 20
13 Enterobacter cloacae 25 20 25 22.5BMC Complementary and Alternative Medicine 2009, 9:34 http://www.biomedcentral.com/1472-6882/9/34
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In this study, we found that tualang honey has variable
but broad-spectrum activities against many different spe-
cies of wound and enteric bacteria. Its activity was compa-
rable to that of manuka honey when tested against certain
bacterial species. Lusby et al. [20] reported that honeys
other than the commercially available antibacterial hon-
eys (e.g., manuka honey) can have equivalent antibacte-
rial activity against some bacteria, whereas Basson and
Grobler [21] found no exceptionally high antimicrobial
activity of honeys from indigenous wild flowers from
South Africa.
We chose the broth dilution method for this study
because it generates more quantitative and precise results
compared to the agar well diffusion method. Moreover,
the MIC values determined by the broth dilution method
were lower (indicating higher activity) than those
obtained using the agar well diffusion method, as diffu-
sion rates of active constituents in agar may be slower
than those in broth [22].
We also performed spectrophotometric assays using
microtiter plates; it is a simple and rapid method, it has a
greater sensitivity than the standard well and disc diffu-
sion methods and the results are highly reproducible [23].
Spectrophotometry can detect inhibitory levels below
those recorded for well or disc diffusion assays [23]. In our
study, visual inspection might not have been accurate
because impurities in the honeys (especially in tualang
honey) might have caused disturbance and imprecision in
the readings. Moreover, a medium containing bacterial
growth not detectable by eye would have been described
as clear by visual inspection, but the growth would have
been detectable spectrophotometrically. These might have
caused the wide variation seen in MIC values determined
by visual inspection and by spectrophotometric measure-
ment (e.g., our results for S. flexneri). Visual inspection
also could not distinguish the percentage of growth in the
turbid wells. MIC determination by visual inspection
might also vary from person to person depending on the
eye of the observer.
Table 2: MBC values (%) of tualang honey and manuka honey
No. Microorganism MBC (%)
Tualang Manuka
1 Streptococcus pyogenes 25 25
2 Coagulase-negative Staphylococci >25 >25
3 Methicillin-resistant Staphylococcus aureus >25 25
4 Streptococcus agalactiae >25 22.5
5 Staphylococcus aureus >25 25
6 Stenotrophomonas maltophilia 25 11.25
7 Acinetobacter baumannii >25 12.5
8 Salmonella enterica Serovar typhi 20 17.5
9 Pseudomonas aeruginosa 25 22.5
10 Proteus mirabilis >25 >25
11 Shigella flexneri >25 >25
12 Escherichia coli >25 17.5
13 Enterobacter cloacae >25 >25
Inhibition of the growth of S. pyogenes (GAS), coagulase-neg- ative Staphylococci (CoNS) and MRSA Figure 1
Inhibition of the growth of S. pyogenes (GAS), coagu-
lase-negative Staphylococci (CoNS) and MRSA.
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Inhibition of the growth of S. maltophilia (STMA) and A. bau- mannii (ACBA) caused by tualang and manuka honeys at dif- ferent concentrations Figure 3
Inhibition of the growth of S. maltophilia (STMA) and 
A. baumannii (ACBA) caused by tualang and manuka 
honeys at different concentrations.
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Having known that the presence of hydrogen peroxide in
honeys contributes to its antibacterial activity, we
screened the non-peroxide activity of both tualang and
manuka honeys and found that the antibacterial activity
persisted after the addition of catalase for both honeys,
suggesting the presence of non-peroxide activity.
Analysis of the inhibition of bacterial growth caused by
different honey concentrations revealed both differences
and similarities in the pattern of inhibition exhibited by
the 13 microorganisms tested in this study. Most bacteria
showed similar growth inhibition patterns for both hon-
eys tested, but some variations were detected. The
observed differences might reflect how each type of bacte-
ria reacts to honey treatment.
Tualang and manuka honeys showed good antimicrobial
activity against S. maltophilia; both honeys yielded the
lowest visual MIC of 8.75% (w/v) against this microor-
ganism. This organism is an aerobic, non-fermentative,
Gram-negative bacterium that causes uncommon but dif-
ficult to treat infections in immunocompetent individu-
als, such as pneumonia, urinary tract infection and blood
stream infection. It can lead to nosocomial infections and
latent pulmonary infections in immunocompromised
patients [24]. S. maltophilia often is difficult to eradicate
because it is naturally resistant to many broad-spectrum
antibiotics, including all carbapenems; moreover, increas-
ing resistance has been reported for co-trimoxazole and
ticarcillin [25]. Thus, the use of tualang honey to treat S.
maltophilia infections should be further investigated.
When compared to manuka honey, tualang honey exhib-
ited better antimicrobial activity against A. baumannii. A.
baumannii is a pathogenic, aerobic, Gram-negative bacil-
lus and most of its isolates are inherently multi-drug
resistant [26]. A. baumannii is an opportunistic pathogen
that usually infects immunocompromised individuals
through open wounds, catheters and breathing tubes.
Multi-drug resistant A. baumannii has emerged as a major
cause of nosocomial infection, with resistance against its
first line of treatment (i.e., carbapenems such as imi-
penem) [27]. Therefore, sterilized tualang honey has the
potential to be used as an alternative agent for wound
infection caused by this bacterium. However, this
approach needs to be further studied.
Haffejee and Moosa [28] discovered that honey is effective
in treating bacterial gastroenteritis in infants. Honey was
reported to be effective when used as a substitute for glu-
cose in oral rehydration and its antibacterial activity short-
ened the duration of bacterial diarrhoea. In our study, the
growth of bacterial species that cause gastric infections,
such as S. typhi, S. flexneri and E. coli, were inhibited by
tualang honey at concentrations between 15% and 22.5%
(w/v). Previous preliminary study on tualang honey also
reported that it has antibacterial activity against E. coli, S.
typhi and S. pyogenes [15]. Thus, when taken orally in its
pure undiluted form, tualang honey may help speed up
recovery from such infections.
The spectrophotometric data obtained in this study
revealed that tualang honey had slightly better inhibitory
Inhibition of the growth of S. agalactiae (STGB) and S. aureus  (STAU) Figure 2
Inhibition of the growth of S. agalactiae (STGB) and 
S. aureus (STAU).
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Inhibition of the growth of S. typhi (SATY), S. flexneri (SHFL)  and E. coli (ESCO) Figure 4
Inhibition of the growth of S. typhi (SATY), S. flexneri 
(SHFL) and E. coli (ESCO).
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Inhibition of the growth of P. aeruginosa (PSAE), P. mirabilis  (PRMI) and E. cloacae (ENCL) Figure 5
Inhibition of the growth of P. aeruginosa (PSAE), P. 
mirabilis (PRMI) and E. cloacae (ENCL).
0.00
20.00
40.00
60.00
80.00
100.00
12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Concentration of honey (%)
%
 
i
n
h
i
b
i
t
i
o
n
Tualang vs. PSAE
Manuka vs. PSAE
Tualang vs. PRMI
Manuka vs. PRMI
Tualang vs. ENCL
Manuka vs. ENCLBMC Complementary and Alternative Medicine 2009, 9:34 http://www.biomedcentral.com/1472-6882/9/34
Page 7 of 8
(page number not for citation purposes)
activity than manuka honey against MRSA. This activity
may turn out to be quite beneficial, as there has been a
discernible increase in difficult-to-treat skin and underly-
ing tissue infections associated with Gram-positive bacte-
ria like MRSA. Thus, more effective treatment is needed to
treat MRSA [8].
The MBC values obtained in this study indicated the min-
imum concentration of honey needed to kill 99.9% of
bacteria. However, the indications for determination of
bactericidal activity are rare and are usually meant for seri-
ous infections, such as in immunocompromised patients
or infections at a site that is difficult to be reached with
available antibiotics. In this study, the MBC of tualang
honey was remarkable against one Gram-positive bacte-
rium (S. pyogenes) and three Gram-negative bacteria (S.
maltophilia, S. typhi and P. aeruginosa).
Most deaths in severely burn-injured patients are due to
burn wound sepsis or complications due to inhalation
injury. Currently, the emerging antimicrobial resistance
trends in burn wound bacterial pathogens are a serious
challenge [11]. Thus, honey with effective antimicrobial
properties against antibiotic-resistant organisms such as
MRSA and multiple-resistant Gram-negative rods such as
Pseudomonas aeruginosa, Acinetobacter spp. and members
of the family Enterobacteriaceae, which have been associ-
ated with infections of burn wounds and sites of major
thermal injury and in nosocomial infections, is much
anticipated [11,29].
Conclusion
Tualang honey exhibited variable activities against many
different microorganisms. In some cases it showed equiv-
alent or better activities than manuka honey, especially
against S. maltophilia and A. baumannii. The potency of
tualang honey against certain microorganisms suggests its
potential to be used as an alternative therapeutic agent for
certain medical conditions, particularly wound infection.
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